W. van Geffen (Leeuwarden, Netherlands), G. Hardavella (Athens, Greece)
Late Breaking Abstract - The role of the transcription factor PU.1 in lung cancer
K. Hohenberger (Erlangen, Germany), D. Trufa (Erlangen, Germany), C. Gebbert (Erlangen, Germany), R. Rieker (Erlangen, Germany), H. Sirbu (Erlangen, Germany), S. Finotto (Erlangen, Germany)
|   |
Late Breaking Abstract - Role of phosphorylated Signal Transducer and Activator of Transcription 5 (pSTAT5) in non-small cell lung cancer (NSCLC)
P. Tausche (Erlangen, Germany), D. Trufa (Erlangen, Germany), C. Geppert (Erlangen, Germany), R. Rieker (Erlangen, Germany), H. Sirbu (Erlangen, Germany), S. Neurath-Finotto (Erlangen, Germany)
| |
Dynamic monitoring of plasma DAMP proteins during various anticancer agents in advanced lung cancer patients
H. Inoue (Fukuoka, Japan), H. Tsutsumi (Fukuoka, Japan), Y. Shiraishi (Fukuoka, Japan), K. Okamura (Fukuoka, Japan), K. Ota (Fukuoka, Japan), Y. Yoneshima (Fukuoka, Japan), E. Iwama (Fukuoka, Japan), K. Tanaka (Fukuoka, Japan), I. Okamoto (Fukuoka, Japan)
| |
Germline mutations in young never-smokers with lung adenocarcinoma
W. Luo (Chengdu, China), W. Li (Chengdu, China)
| |
Analysis of the structures and functions of N-glycans of MET
A. Saitou (Sapporo, Hokkaido, Japan), M. Takahashi (Sapporo, Hokkaido, Japan), S. Yokoyama (Sapporo, Hokkaido, Japan), N. Fujitani (Sapporo, Hokkaido, Japan), S. Ariki (Sapporo, Hokkaido, Japan), A. Saito (Sapporo, Hokkaido, Japan), K. Kuronuma (Sapporo, Hokkaido, Japan), H. Chiba (Sapporo, Hokkaido, Japan), H. Takahashi (Sapporo, Hokkaido, Japan)
| |
Molecular hallmarks of smoking in the Gauting lung adenocarcinoma donors
A. Lamort (München, Germany), M. Pepe (München, Germany), S. Behrend (München, Germany), I. Lilis (Rio, Greece), G. Ntaliarda (Rio, Greece), M. Spella (Rio, Greece), W. Kujawa (München, Germany), M. Lindner (Gauting, Germany), I. Koch (Gauting, Germany), R. Hatz (Gauting, Germany), J. Behr (Gauting, Germany), G. Stathopoulos (München, Germany)
| |
Reduction of drug resistance through calcium control in epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) resistant lung cancer cells
S. Yang (Iksan, Republic of Korea), M. Kim (Iksan, Republic of Korea), S. Kim (Iksan, Republic of Korea), M. Kim (Iksan, Republic of Korea)
| |
Relationship between Cancer-associated fibroblast and programmed death ligand 1 expression in non-small cell lung cancer
Y. Kogue (Suzuka, Japan), H. Kobayashi (Suzuka, Japan)
| |
IMMUNOLOGICAL EVENTS AND SURVIVAL IN LUNG CANCER PATIENTS WITH COPD
J. Tang (Barcelona, Spain), X. Wang (Barcelona, Spain), L. Qin (Barcelona, Spain), V. Curull (Barcelona, Spain), M. Mateu-Jiménez (Barcelona, Spain), D. Ramis-Cabrer (Barcelona, Spain), L. Pijuan (Barcelona, Spain), A. Rodríguez-Fuster (Barcelona, Spain), R. Aguiló (Barcelona, Spain), E. Barreiro Portela (Barcelona, Spain)
| |
Molecular profiling of Sq-NSCLC with enhanced FGFR1-4 and MET gene expression – NGS pilot study.
J. Moes-Sosnowska (Warsaw, Poland), E. Szczepulska-Wojcik (Warsaw, Poland), A. Rozy (Warsaw, Poland), R. Langfort (Warsaw, Poland), P. Rudzinski (Warsaw, Poland), T. Orlowski (Warsaw, Poland), M. Skupinska (Kielpin/ Lomianki, Poland), D. Popiel (Kielpin/ Lomianki, Poland), M. Wieczorek (Kielpin/ Lomianki, Poland), A. Stanczak (Kielpin/ Lomianki, Poland), J. Chorostowska-Wynimko (Warsaw, Poland)
| |
Biomarkers of lung cancer based on the expression of genes, transposons and repetitive elements
M. Arroyo Varela (Malaga, Spain), E. Salcedo Lobera (Malaga, Spain), R. Larrosa Jiménez (Malaga, Spain), M. Claros Díaz (Malaga, Spain), R. Bautista Moreno (Malaga, Spain)
| |
EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
T. Cai (Suzhou, China), J. Zhou (Suzhou, China), Y. Zhang (Suzhou, China), Y. Zeng (Suzhou, China), W. Du (Suzhou, China), T. Liu (Suzhou, China), Y. Fu (Suzhou, China), J. Huang (Suzhou, China), J. Zhu (Suzhou, China), C. Ling (Suzhou, China), Z. Liu (Suzhou, China)
| |
The genetic expression LGI3 (Leucine rich repeat LGI family member 3) among different NSLC cell lines and its effect on proliferation of cancer cells
J. Shin (Seoul, Republic of Korea), I. Park (Seoul, Republic of Korea), J. Jung (Seoul, Republic of Korea), J. Choi (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), H. Yun (Seoul, Republic of Korea)
| |
Immunomodulating properties of FasL+ lung cancer cells identified in lymph nodes aspirates of NSCLC patients
A. Raniszewska (Warszawa, Poland), I. Kwiecien (Warszawa, Poland), E. Rutkowska (Warszawa, Poland), R. Sokolowski (Warszawa, Poland), J. Domagala-Kulawik (Warszawa, Poland)
| |
Immunosuppressive properties of human PD-1+ PDL-1+ dendritic cell from Lymph Nodes Aspirates of NSCLC patients.
I. Kwiecien (Warsaw, Poland), E. Rutkowska (Warsaw, Poland), R. Sokolowski (Warsaw, Poland), J. Bednarek (Warsaw, Poland), A. Raniszewska (Warsaw, Poland), K. Jahnz-Rózyk (Warsaw, Poland), P. Rzeepecki (Warsaw, Poland), J. Domagala-Kulawik (Warsaw, Poland)
| |
Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway
H. Zhu (Shanghai, China), L. Pan (Shanghai, China), H. Ge (Shanghai, China)
| |
Association between cyclooxygenase inhibitor use and efficacy of immunotherapy: a retrospective study
O. Kanai (Kyoto, Japan), K. Fujita (Kyoto, Japan), M. Okamura (Kyoto, Japan), K. Horimoto (Kyoto, Japan), M. Hashimoto (Kyoto, Japan), K. Nakatani (Kyoto, Japan), S. Sawai (Kyoto, Japan), T. Mio (Kyoto, Japan)
| |
An implantable rutin incorporated PCL/collagen electrospun nanofibers for effectivegrowth inhibition of lung cancer cells: Possible application in prevention of lung cancerlocal recurrence
S. celik (istanbul, Turkey), S. Doosti (Istanbul, Turkey), M. Karimi (Ahvaz, Islamic Republic of Iran)
| |
MiR-34a favours macrophage polarization switch from M2 to M1 phenotype in non small cell lung cancer (NSCLC)
S. Arora (New Delhi (Delhi), India), S. Ali (New Delhi (Delhi), India), M. Syed (New Delhi (Delhi), India)
| |